Chemopreventive effects of 2-(allylthio)pyrazine

被引:17
作者
Kim, ND [1 ]
Kim, SG [1 ]
机构
[1] Seoul Natl Univ, Coll Pharm, Seoul 151742, South Korea
关键词
2-(allylthio)pyrazine; chemoprevention; radioprotection; hepatoprotective agent; cytochrome P450; epoxide hydrolase; glutathione S-transferase;
D O I
10.1007/BF02976531
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of organosulfur compounds were synthesized with the aim of developing chemopreventive compounds active against hepatotoxicity and chemical carcinogenesis. 2-(Allylthio) pyrazine (2-AP) was effective in inhibiting cytochrome P450 2E1-mediated catalytic activities and protein expression, and in inducing microsomal epoxide hydrolase and major glutathione S-transferases. 2-AP reduced the hepatotoxicity caused by toxicants and elevated cellular GSH content. Development of skin tumors, pulmonary adenoma and aberrant crypt foci in colon by various chemical carcinogens was inhibited by 2-AP pretreatment. Anticarcinogenic effects of 2-AP at the stage of initiation of tumors were also observed in the aflatoxin B-1 (AFB(1))-induced three-step medium-term hepatocarcinogenesis model. Reduction of AFB(1)-DNA adduct by 2-AP appeared to result from the decreased formation of AFB(1)-8,9-epoxide via suppression of cytochrome P450, while induction of GST by 2-AP increases the excretion of glutathione-conjugated AFB(1). 2-AP was a radioprotective agent effective against the lethal dose of total body irradiation and reduced radiation-induced injury in association with the elevation of detoxifying gene expression. 2-AP produces reactive oxygen species in vivo, which is not mediated with the thiol-dependent production of oxidants and that NF-kappa B activation is not involved in the induction of the detoxifying enzymes. The mechanism of chemoprotection by 2-AP may involve inhibition of the P450-mediated metabolic activation of chemical carcinogens and enhancement of electrophilic detoxification through induction of phase II detoxification enzymes which would facilitate the clearance of activated metabolites through conjugation reaction.
引用
收藏
页码:99 / 107
页数:9
相关论文
共 65 条
[1]  
BENNETT RA, 1981, CANCER RES, V41, P650
[2]  
BOYLAND E, 1979, ADV CANCER RES, V29, P175
[3]   INHIBITION OF CYTOCHROME-P-450 2E1 BY DIALLYL SULFIDE AND ITS METABOLITES [J].
BRADY, JF ;
ISHIZAKI, H ;
FUKUTO, JM ;
LIN, MC ;
FADEL, A ;
GAPAC, JM ;
YANG, CS .
CHEMICAL RESEARCH IN TOXICOLOGY, 1991, 4 (06) :642-647
[4]   CYTOCHROME-P450 SPECIFICITIES OF ALKOXYRESORUFIN O-DEALKYLATION IN HUMAN AND RAT-LIVER [J].
BURKE, MD ;
THOMPSON, S ;
WEAVER, RJ ;
WOLF, CR ;
MAYER, RT .
BIOCHEMICAL PHARMACOLOGY, 1994, 48 (05) :923-936
[5]   IDENTIFICATION OF PRINCIPAL AFLATOXIN B1-DNA ADDUCT FORMED INVIVO IN RAT-LIVER [J].
CROY, RG ;
ESSIGMANN, JM ;
REINHOLD, VN ;
WOGAN, GN .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1978, 75 (04) :1745-1749
[6]   MECHANISM OF AFLATOXIN CARCINOGENESIS [J].
EATON, DL ;
GALLAGHER, EP .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1994, 34 :135-172
[7]   STRUCTURAL IDENTIFICATION OF MAJOR DNA ADDUCT FORMED BY AFLATOXIN-B1 INVITRO [J].
ESSIGMANN, JM ;
CROY, RG ;
NADZAN, AM ;
BUSBY, WF ;
REINHOLD, VN ;
BUCHI, G ;
WOGAN, GN .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1977, 74 (05) :1870-1874
[8]   MOLECULAR EPIDEMIOLOGY OF AFLATOXIN EXPOSURES - VALIDATION OF AFLATOXIN-N7-GUANINE LEVELS IN URINE AS A BIOMARKER IN EXPERIMENTAL RAT MODELS AND HUMANS [J].
GROOPMAN, JD ;
WILD, CP ;
HASLER, J ;
CHEN, JS ;
WOGAN, GN ;
KENSLER, TW .
ENVIRONMENTAL HEALTH PERSPECTIVES, 1993, 99 :107-113
[9]  
Ha TG, 1998, RES COMMUN MOL PATH, V102, P69
[10]  
HA TG, 1999, IN PRESS CHEMICOBIOI